FI902416A0 - Förfarande för framställning av terapeutiskt användbara aminosyra-antagonister - Google Patents

Förfarande för framställning av terapeutiskt användbara aminosyra-antagonister

Info

Publication number
FI902416A0
FI902416A0 FI902416A FI902416A FI902416A0 FI 902416 A0 FI902416 A0 FI 902416A0 FI 902416 A FI902416 A FI 902416A FI 902416 A FI902416 A FI 902416A FI 902416 A0 FI902416 A0 FI 902416A0
Authority
FI
Finland
Prior art keywords
amino acid
therapeutically useful
acid antagonists
useful amino
making therapeutically
Prior art date
Application number
FI902416A
Other languages
English (en)
Finnish (fi)
Other versions
FI95795C (sv
FI95795B (sv
Inventor
Boyd Lynn Harrison
Bruce Michael Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI902416A0 publication Critical patent/FI902416A0/sv
Application granted granted Critical
Publication of FI95795B publication Critical patent/FI95795B/sv
Publication of FI95795C publication Critical patent/FI95795C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
FI902416A 1989-05-16 1990-05-15 Förfarande för framställning av terapeutiskt användbara aminosyra-antagonister FI95795C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16
US35242389 1989-05-16

Publications (3)

Publication Number Publication Date
FI902416A0 true FI902416A0 (sv) 1990-05-15
FI95795B FI95795B (sv) 1995-12-15
FI95795C FI95795C (sv) 1996-03-25

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902416A FI95795C (sv) 1989-05-16 1990-05-15 Förfarande för framställning av terapeutiskt användbara aminosyra-antagonister

Country Status (19)

Country Link
EP (1) EP0398283B1 (sv)
JP (1) JP3014001B2 (sv)
KR (1) KR0169107B1 (sv)
CN (1) CN1027369C (sv)
AT (1) ATE113597T1 (sv)
AU (1) AU626418B2 (sv)
DE (1) DE69013750T2 (sv)
DK (1) DK0398283T3 (sv)
ES (1) ES2066035T3 (sv)
FI (1) FI95795C (sv)
GR (1) GR3014893T3 (sv)
HU (1) HU214322B (sv)
IE (1) IE64671B1 (sv)
IL (1) IL94377A (sv)
NO (1) NO177141C (sv)
NZ (1) NZ233641A (sv)
PT (1) PT94042B (sv)
TW (1) TW207950B (sv)
ZA (1) ZA903588B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
JP3465794B2 (ja) * 1991-02-27 2003-11-10 メレルファーマスーティカルズ インコーポレイテッド Ｎｍｄａ拮抗剤
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
WO2001047891A1 (fr) 1999-12-28 2001-07-05 Eisai Co., Ltd. Composes heterocylciques contenant des groupes de sulfamide
ES2263779T3 (es) * 2001-03-14 2006-12-16 Grunenthal Gmbh Pirazolopirimidinas sustituidas.
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
HUE027857T2 (en) 2008-04-11 2016-11-28 Merck Patent Gmbh Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
CN108659000B (zh) * 2017-05-03 2020-03-31 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
ZA903588B (en) 1991-02-27
DE69013750D1 (de) 1994-12-08
JP3014001B2 (ja) 2000-02-28
CN1047292A (zh) 1990-11-28
DE69013750T2 (de) 1995-05-24
KR0169107B1 (ko) 1999-01-15
IE901750L (en) 1990-11-16
HU903031D0 (en) 1990-09-28
CN1027369C (zh) 1995-01-11
ATE113597T1 (de) 1994-11-15
IL94377A0 (en) 1991-03-10
EP0398283A1 (en) 1990-11-22
NO177141C (no) 1995-07-26
NO902179D0 (no) 1990-05-15
GR3014893T3 (en) 1995-05-31
ES2066035T3 (es) 1995-03-01
IL94377A (en) 1997-01-10
JPH0311067A (ja) 1991-01-18
PT94042A (pt) 1991-01-08
AU626418B2 (en) 1992-07-30
FI95795C (sv) 1996-03-25
PT94042B (pt) 1997-05-28
TW207950B (sv) 1993-06-21
KR900018112A (ko) 1990-12-20
NO902179L (no) 1990-11-19
EP0398283B1 (en) 1994-11-02
AU5491490A (en) 1990-11-22
NZ233641A (en) 1992-07-28
IE64671B1 (en) 1995-08-23
HUT54657A (en) 1991-03-28
NO177141B (no) 1995-04-18
FI95795B (sv) 1995-12-15
DK0398283T3 (da) 1994-11-28
HU214322B (hu) 1998-03-02

Similar Documents

Publication Publication Date Title
FI902416A0 (sv) Förfarande för framställning av terapeutiskt användbara aminosyra-antagonister
DE69033308D1 (de) Decahydro-isochinolin-derivate
FI892881A (sv) Förfarande för framställning av terapeutiskt användbara aminosyraderivat
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
PT81991A (fr) Procede pour l'obtention de derives analogues de la pepstatine inhibidors de la renine et de proteases acides
IT1219084B (it) Procedimento per la fabbricazione di cemento
DK0624574T3 (da) Hidtil ukendte prostaglandinanaloger
IT1218256B (it) Procedimento per l'allontanamento ad umido dell'aniride solforosa
FI875295A0 (sv) Förfarande för framställning av en hirudinvariant
BR9206404A (pt) Heteroaril-polimiaminas sintéticas como antagonistas de neurotransmissores aminoácidos excitadores
IT8819603A0 (it) Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
IT1231751B (it) Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
IT8148270A0 (it) Composti di n-(cicloalchil)ammino acido utili come inibitori dell'enzima di conversione dell'angiotensi na i
BG35593A3 (en) Method for separating aminoacids in optical antipodes
IT8224380A0 (it) Amminoacidi fosfinilalcanoici utili come agenti ipotensivi.
ES550013A0 (es) Un metodo de produccion de un polipeptido funcional
IT1194171B (it) Procedimento di produzione dell'aspartame
KR870700616A (ko) 치환된 아미노 제초제의 개량된 제조방법
IT7868375A0 (it) Procedimento per la produzione difibre inorganiche a base di solfatodi calcio
DK196489D0 (da) Carbamatderivater samt en fremgangsmaade til fremstilling heraf
IT1203844B (it) Procedimento per la produzione di un filato di poliammide-6
IT8423115A1 (it) Processo per la produzione di corpi formati autoestinguenti a base di policaprolattame

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.